Synthesis of 2,6-Dialkyl(aryl)purine Nucleosides by Exploiting the Reactivity of Nebularine N1-Oxide towards Grignard Reagents

The synthesis of 2,6-dialkyl(aryl)purine nucleosides by application of a double addition of Grignard reagents to N1-oxide purine nucleosides is described. The synthetic protocol exploits the reactivity of both the C6–N1–O– and C2–N1–O– moieties of the purine base. The overall process consists of initial Grignard reagent addition to the C6 of nebularine N1-oxide followed by aromatization to give a C6-substituted nucleoside. Regeneration of the N1-oxide is then followed by a second Grignard addition at C2 causing the opening of the pyrimidine ring. Cyclization of the transiently opened pyrimidine is then driven by aromatization of the system to afford the final purine system.

[1]  G. Piccialli,et al.  A Facile Synthesis of 5′-Fluoro-5′-deoxyacadesine (5′-F-AICAR): A Novel Non-phosphorylable AICAR Analogue , 2012, Molecules.

[2]  N. Luedtke,et al.  Stereoselective N-glycosylation of 2-deoxythioribosides for fluorescent nucleoside synthesis. , 2012, The Journal of organic chemistry.

[3]  G. Piccialli,et al.  Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. , 2012, Chemical communications.

[4]  Y. Mély,et al.  A universal nucleoside with strong two-band switchable fluorescence and sensitivity to the environment for investigating DNA interactions. , 2012, Journal of the American Chemical Society.

[5]  L. Agrofoglio,et al.  One-pot Sonogashira-cyclization protocol to obtain substituted furopyrimidine nucleosides in aqueous conditions , 2012 .

[6]  G. Piccialli,et al.  Solid-Phase Synthesis of a New Diphosphate 5-Aminoimidazole-4-carboxamide Riboside (AICAR) Derivative and Studies toward Cyclic AICAR Diphosphate Ribose , 2011, Molecules.

[7]  G. Piccialli,et al.  Probing the reactivity of nebularine N1-oxide. A novel approach to C-6 C-substituted purine nucleosides , 2011 .

[8]  R. Olsson,et al.  Reactions between Grignard reagents and heterocyclic N-oxides: stereoselective synthesis of substituted pyridines, piperidines, and piperazines. , 2011, Organic & biomolecular chemistry.

[9]  Ling Peng,et al.  Triazole nucleoside derivatives bearing aryl functionalities on the nucleobases show antiviral and anticancer activity. , 2010, Mini reviews in medicinal chemistry.

[10]  A. Miroshnikov,et al.  New Trends in Nucleoside Biotechnology , 2010, Acta naturae.

[11]  G. Piccialli,et al.  A solid-phase approach to the synthesis of N-1-alkyl analogues of cyclic inosine-diphosphate-ribose (cIDPR) , 2010 .

[12]  G. Piccialli,et al.  Facile Solid‐Phase Synthesis of AICAR 5′‐Monophosphate (ZMP) and Its 4‐N‐Alkyl Derivatives , 2010 .

[13]  S. Manta,et al.  Antiviral Unsaturated Nucleosides , 2008 .

[14]  G. Piccialli,et al.  Synthesis of 4-N-alkyl and ribose-modified AICAR analogues on solid support , 2008 .

[15]  A. Romieu,et al.  Development of a new nonpeptidic self-immolative spacer. Application to the design of protease sensing fluorogenic probes. , 2008, Organic letters.

[16]  R. Olsson,et al.  Reaction of pyridine N-oxides with Grignard reagents : a stereodefined synthesis of substituted dienal oximes , 2007 .

[17]  Michal Hocek,et al.  Synthesis of (purin-6-yl)acetates and 6-(2-hydroxyethyl)purines via cross-couplings of 6-chloropurines with the Reformatsky reagent , 2007 .

[18]  R. Olsson,et al.  Synthesis of 2-substituted pyridines via a regiospecific alkylation, alkynylation, and arylation of pyridine N-oxides. , 2007, Organic letters.

[19]  G. Piccialli,et al.  Synthesis of N-1 and ribose modified inosine analogues on solid support , 2007 .

[20]  F. Qing,et al.  Fluorinated nucleosides as antiviral and antitumor agents. , 2006, Current topics in medicinal chemistry.

[21]  G. Bifulco,et al.  Callipeltins F–I: new antifungal peptides from the marine sponge Latrunculia sp. , 2006 .

[22]  M. Otto,et al.  Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides. , 2005, Journal of medicinal chemistry.

[23]  Z. Hong,et al.  Synthesis of 9-(2-β-C-methyl-β-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication , 2005 .

[24]  R. Pohl,et al.  Facile and efficient synthesis of 6-(hydroxymethyl)purines. , 2004, Organic letters.

[25]  P. Guenot,et al.  Palladium-catalyzed synthesis of uridines on polystyrene-based solid supports. , 2004, Journal of combinatorial chemistry.

[26]  W. Waud,et al.  Purine nucleoside antimetabolites in development for the treatment of cancer. , 2004, Current opinion in investigational drugs.

[27]  S. Izuta,et al.  DNA polymerases as targets of anticancer nucleosides. , 2004, Current drug targets.

[28]  Michal Hocek,et al.  An efficient synthesis of 2-substituted 6-methylpurine bases and nucleosides by Fe- or Pd-catalyzed cross-coupling reactions of 2,6-dichloropurines. , 2003, The Journal of organic chemistry.

[29]  L. Agrofoglio,et al.  Palladium-assisted routes to nucleosides. , 2003, Chemical reviews.

[30]  Michal Hocek.  Syntheses of Purines Bearing Carbon Substituents in Positions 2, 6 or 8 by Metal- or Organometal-Mediated C−C Bond-Forming Reactions , 2003 .

[31]  L. Gundersen,et al.  Cytotoxic and antibacterial activity of 2-oxopurine derivatives. , 2002, Bioorganic & medicinal chemistry letters.

[32]  L. Gundersen,et al.  Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines. , 2002, Journal of medicinal chemistry.

[33]  Michal Hocek,et al.  CYTOSTATIC 6-ARYLPURINE NUCLEOSIDES IV + . SYNTHESIS OF 2-SUBSTITUTED 6-PHENYLPURINE RIBONUCLEOSIDES , 2002 .

[34]  A. Fournet,et al.  Expeditious preparation of 2-substituted quinolines , 2001 .

[35]  T. S. Rao,et al.  DNA with Altered Bases , 2001 .

[36]  Michal Hocek,et al.  Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides , 2001 .

[37]  L. Gundersen,et al.  Synthesis of 6-substituted purin-2-ones with potential cytokinin activity , 2001 .

[38]  V. Bonnet,et al.  New Syntheses of Substituted Pyridines via Bromine–Magnesium Exchange , 2000 .

[39]  G. Becher,et al.  The influence of modified purine bases on the stability of parallel DNA. , 2000, Bioorganic & medicinal chemistry letters.

[40]  L. Gundersen,et al.  Regiochemistry in addition of Grignard reagents to N,N′-dibenzylated 2-purinones , 1996 .

[41]  S. Knapp.  Synthesis of Complex Nucleoside Antibiotics , 1995 .

[42]  R. Kellogg,et al.  Reactions of aryl Grignard reagents with pyridine 1-oxide. Structure of the addition products , 1971 .